Skip to content
S8463Senate2023-2024 SessionSame asA9047

Legalize All Hemp Products

Official title

“Relates to the regulation of cannabinoid hemp products”

Sponsor Luis R. SepúlvedaSD-32+1 co-sponsorAffects Legal
Status
In Senate Committee
Investigations And Government Operations
Impact
7/10
Significant
Passage
0%

Bill progress

Step 2 of 7

In committee · Investigations And Government Operations

What's happening

This bill repeals certain emergency regulations and allows licensed retailers to sell all forms of cannabinoid hemp with updated labeling requirements.

Why it matters

  1. Expands what can be sold by licensed hemp retailers. The bill allows all forms of cannabinoid hemp to be sold by licensed retailers, rolling back previous restrictions on certain product types (such as Delta-8 and Delta-10 THC), which could significantly increase the variety of hemp products available to consumers and potentially boost the hemp industry in New York.

  2. Limits regulatory power over sales. By making any rules or regulations that prohibit the sale of any form of cannabinoid hemp “null and void,” the bill sharply curtails the authority of state agencies to restrict which hemp products can be sold in the future, creating a more stable environment for businesses and possibly limiting future public health interventions.

  3. Updates and simplifies labeling requirements. The legislation replaces complex and potentially confusing labeling and dosing requirements with a streamlined set of mandatory labels, including nutrition info, dosage per serving, a health disclaimer, and manufacturer details. This could make it easier for businesses to comply and for consumers to understand what they are buying, but may also reduce regulatory oversight of product potency and safety.

  4. Changes age restriction for smokable hemp. The bill modifies the law to allow the sale of smokable hemp flower products to anyone 21 or older (regardless of dispensary type), which could expand access to these products but may also raise concerns about youth use and public health impacts associated with inhalable hemp products.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Legalize All Hemp Products

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Luis R. Sepúlveda

Senator · Senate District 32

Chair, Cities 1

1 Co-sponsor

History

  1. Referred to investigations and government operations

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A9047Assembly

Expand Hemp Product Sales

In Assembly Committee · Economic Development · Sponsor Charles Fall

Impact 7 · Significant0% to pass

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

8463

IN SENATE

February 1, 2024

Introduced by Sen. SEPULVEDA -- read twice and ordered printed, and when printed to be committed to the Committee on Investigations and Government Operations

AN ACT to amend the cannabis law, in relation to the sale of cannabinoid hemp products; and directing the office of cannabis management to repeal certain emergency regulations

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. The office of cannabis management shall repeal the cannabinoid hemp emergency regulations adopted by such office on July 27th, 2023.

§ 2. Subdivisions 52 and 53 of section 3 of the cannabis law are amended to read as follows:

52. "THC" means Delta-9-tetrahydrocannabinol[; Delta-8-tetrahydrocannabinol; Delta-10-tetrahydrocannabinol and the optical isomer of such substances].

53. "Total THC" means the [sum of the percentage by weight or volume measurement of tetrahydrocannabinolic acid multiplied by 0.877, plus, the percentage by weight or volume measurement of THC] dry weight total percentage of Delta-9-tetrahydrocannabinol in each product.

§ 3. Section 91 of the cannabis law is amended by adding a new closing paragraph to read as follows:

Commencing on January first, two thousand twenty-four, a retailer licensed by the office pursuant to this article or any applicable rule shall be permitted to sell any and all forms of cannabinoid hemp; provided that such forms of cannabinoid hemp meet the requirements set forth in this article. The cannabis control board shall have the authority to promulgate any rules necessary to ensure the safety of cannabinoid hemp, so long as said rules do not infringe upon the ability of licensed hemp retailers to sell cannabinoid hemp. Any prior or future rules, policies, or regulations promulgated by the board or any other rulemaking body to prohibit the selling of any form of cannabinoid hemp shall be null and void.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD13669-01-3

§ 4. Subdivision 13 of section 91 of the cannabis law is amended to read as follows:

13. Any cannabinoid hemp flower product clearly labeled or advertised for the purposes of smoking, or in the form of a cigarette, cigar, or pre-roll, or packaged or combined with other items designed to facilitate smoking such as rolling papers or pipes, shall only be offered for sale [in adult-use cannabis retail dispensaries licensed pursuant to article four of this chapter] to persons twenty-one years of age and older.

§ 5. Subdivision 2 of section 103 of the cannabis law is amended to read as follows:

2. [The board may, by rules and regulations, require processors to establish a code, including, but not limited to QR code, for labels and establish methods and procedures for determining, among other things, serving sizes or dosages for cannabinoid hemp, hemp extract and products derived therefrom, active cannabinoid concentration per serving size, number of servings per container, and the growing region, state or country of origin if not from the United States. Such rules and regulations may require an appropriate fact panel that incorporates data regarding serving sizes and potency thereof] Notwithstanding any law, rule, or regulation to the contrary, all hemp-derived cannabinoid products must meet the following labeling requirements:

(a) nutrition label with serving size;

(b) a warning label that the product is not meant to treat or cure any medical ailment and that it is not regulated by the FDA;

(c) the amount of hemp-derived product in each serving of the product in milligrams; and

(d) the address of the manufacturer or distributor.

§ 6. This act shall take effect immediately.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the cannabis law, in relation to the sale of cannabinoid hemp products; and directing the office of cannabis management to repeal certain emergency regulations

Purpose

The legislation will ensure that licensed hemp dealers are allowed to distribute and/or sell hemp-derived cannabinoid products so long as those products meet the definition of cannabinoid hemp defined by the 2018 United States Farm Law and comply with packaging, labeling, and age requirements set forth in this bill.

Summary of provisions

MRTA Article 1, Section 3, subsections 52 and 53 are amended by altering the definitions to better reflect federal regulations to which they now read:

Read the full memo (678 words)

52. "THC" means Delta-9-tetrahydrocannabinol.

53. "Total THC" means the dry weight total percentage of Delta-9-tetrah- ydrocannabinol in each product. MRTA Article 5, Section 91 is amended to add new subsection two (2) which shall read:

Commencing on January 1, 2024, a retailer licensed by the office pursu- ant to this Article or any applicable rule shall be permitted to sell any and all forms of Cannabinoid Hemp; provided that such forms of Cannabinoid Hemp meet the requirements set forth in this article. The cannabis control board shall have the authority to promulgate any rules necessary to ensure the safety of Cannabinoid Hemp, so long as said rules do not infringe upon the ability of licensed hemp retailers to sell Cannabinoid Hemp. Any prior or future rules, policies, or regu- lations promulgated by the board or any other rulemaking body to prohib- it the selling of any form of cannabinoid hemp shall become null and void.

Subdivision 13 of section 91 of the Cannabis Law is amended to apply a 21-year age requirement for the purchase of such products.

Subdivision 2 of section 103 of the Cannabis Law is amended to remove language granting authority to the Cannabis Control Board to require processors to establish a code for labels and establish methods and procedures for determining serving and package sizes or dosages for cannabinoid hemp among other things.

This language is replaced with the following: Notwithstanding any law, rule or regulation to the contrary, all hemp-derived cannabinoid products must meet the following labeling requirements:

(a) Nutrition label with serving size;

(b) A warning label that the product is not meant to treat or cure any medical ailment that it is not regulated by the FDA;

(c) The amount of hemp-derived product in each serving of the product in milligrams; and

(d) The address of the manufacturer or distributor.

Justification

Over the last several years, states across the country have ended the prohibition of hemp-derived cannabis products. New York has been no different as it recently legalized recreational marijuana and ended the prohibition of cannabis. However, recently enacted regulations by the Cannabis Control Board threaten to criminalize the sale of certain hemp- derived products. The decision to make certain hemp-derived cannabinoids illegal to distribute or sell in a licensed environment will once again turn law-abiding citizens and business owners into criminals in the eyes of the state. This would greatly hinder the work being done to aid those disproportionately impacted communities most affected by the prohibition of cannabis.

There is no justification as to why licensed and regulated businesses should not be allowed to distribute or sell hemp-derived cannabinoid products in a safe manner. This bill would protect the free market of the hemp industry and ensure that the entirety of the hemp plant is available in the free market and that a monopoly of cannabinoid hemp products does not arise within marijuana dispensaries.

Thus, this legislation will ensure greater public accessibility to cannabinoid hemp products , provided that those products are sold in a licensed and regulated manner. All cannabinoid hemp products that meet the definition in Article 5 of the MRTA should be permitted to be distributed or sold by licensed dealers, regardless if they are within hemp retail locations or marijuana dispensaries.

Legislative history

S.9165 of 2021-22: New Bill, Civil Service and Pensions

Fiscal implications

None

Local fiscal implications

None

Effective date

Immediately

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.